Novo Nordisk shares fell 9% today following news that the weight loss drug CagriSema was not as effective as expected in clinical trials. Investors may not be happy with such news, but on the other hand, this decline can be used to increase the position.
What do you think about this news? Are you buying $NVO after today's drop?
I've got a smaller position and I'll hold for now. Right now I'm more buying and taking advantage of the downturn in tech stocks.
I bought$NVO after the big drop, but I plan to increase my position today. The fact that the drug is not doing so well is not good news, but it is still a great success.